BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32516177)

  • 1. Low glutamate dehydrogenase levels are associated with colonization in Clostridium difficile PCR-only positive patients with inflammatory bowel disease.
    Desai M; Knight K; Gray JM; Nguyen V; Boone J; Sorrentino D
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1099-1105. PubMed ID: 32516177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Risk Factors for Clostridium difficile Infection Based on Immunochromatography Testing and Toxigenic Culture Assay.
    Ohshima T; Osaki T; Yamamoto Y; Asai S; Miyachi H; Kamiya S
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD; Cliff PR; Smith S; Milner M; French GL
    J Hosp Infect; 2010 Jan; 74(1):48-54. PubMed ID: 19900734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative fecal lactoferrin in toxin-positive and toxin-negative Clostridium difficile specimens.
    LaSala PR; Ekhmimi T; Hill AK; Farooqi I; Perrotta PL
    J Clin Microbiol; 2013 Jan; 51(1):311-3. PubMed ID: 23135940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective Evaluation of the mariPOC Test for Detection of Clostridioides difficile Glutamate Dehydrogenase and Toxins A/B.
    Savolainen R; Koskinen JM; Mentula S; Koskinen JO; Kaukoranta SS
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31941691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
    Cho DH; Kim SH; Jeon CH; Kim HT; Park KJ; Kim J; Kwak J; Kwan BS; Kong S; Lee JW; Kim KM; Wi YM
    Ann Clin Microbiol Antimicrob; 2024 Apr; 23(1):35. PubMed ID: 38664689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
    Viazis N; Pontas C; Karmiris K; Dimas I; Fragaki M; Paspatis G; Drygiannakis I; Koutroubakis IE; Moschovis D; Tzouvala M; Theocharis G; Tsolias C; Thomopoulos K; Zampeli E; Axiaris G; Michopoulos S; Belesiotou E; Banasa M; Maraki S; Kouskoumpekou F; Apostolopoulos G; Stamouli V; Prifti H; Mantzaris GJ
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):773-776. PubMed ID: 30973416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat stool testing for Clostridium difficile using enzyme immunoassay in patients with inflammatory bowel disease increases diagnostic yield.
    Deshpande A; Pasupuleti V; Patel P; Pant C; Pagadala M; Hall G; Hu B; Jain A; Rolston DD; Sferra TJ; Atreja A
    Curr Med Res Opin; 2012 Sep; 28(9):1553-60. PubMed ID: 22852871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: a clinical comparison of fecal tests.
    Barkin JA; Nandi N; Miller N; Grace A; Barkin JS; Sussman DA
    Dig Dis Sci; 2012 Oct; 57(10):2592-9. PubMed ID: 22576711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
    Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.
    Origüen J; Corbella L; Orellana MÁ; Fernández-Ruiz M; López-Medrano F; San Juan R; Lizasoain M; Ruiz-Merlo T; Morales-Cartagena A; Maestro G; Parra P; Villa J; Delgado R; Aguado JM
    Clin Microbiol Infect; 2018 Apr; 24(4):414-421. PubMed ID: 28811244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of toxigenic Clostridioides [Clostridium] difficile: Usefulness of two commercially available enzyme immunoassays and a PCR assay on stool samples and stool isolates.
    Legaria MC; Rollet R; Di Martino A; Castello L; Barberis C; Rossetti MA; Guardati MC; Fernández Canigia L; Carloni G; Litterio M; Rocchi M; Anchart EG; Trejo FM; Minnaard J; Klajn D; Predari SC
    Rev Argent Microbiol; 2018; 50(1):36-44. PubMed ID: 28988901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance Comparison of a Novel Rapid Stand-alone Molecular Test and a 2-Step Diagnostic Algorithm for Clostridioides difficile Detection in Children.
    Brotons P; Saucedo J; Simó S; Gené A; Muñoz-Almagro C
    Pediatr Infect Dis J; 2021 Feb; 40(2):169-172. PubMed ID: 33055503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
    Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the VIDAS glutamate dehydrogenase assay for the detection of Clostridium difficile.
    Shin BM; Lee EJ; Moon JW; Lee SY
    Anaerobe; 2016 Aug; 40():68-72. PubMed ID: 27282799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Diagnostic Algorithm for the Detection of Clostridium difficile-Associated Diarrhea.
    Yoldaş Ö; Altındiş M; Cufalı D; Aşık G; Keşli R
    Balkan Med J; 2016 Jan; 33(1):80-6. PubMed ID: 26966622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.